Saturday, May 25, 2013 11:06am EDT
ONXX - Onyx Pharmaceuticals Inc - Insider Transactions
SIC: 2836 - Biological Products, (no Disgnostic Substances)
CIK: 1012140, EIN: 94-3154463, INC: DE, FY: 12-31
CIK: 1012140, EIN: 94-3154463, INC: DE, FY: 12-31
SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
May 21 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 850 | Gift at $0.00 | $0 | |
MMay 14 2013 | ONXX | Onyx Pharmaceuticals Inc | Lasowski Juergen | EVP, Corp. Dev, Strategy | 4,182 | Sale at $96.60 | $403,967 | |
MMay 13 2013 | ONXX | Onyx Pharmaceuticals Inc | Torley Helen | EVP, Chief Commercial Officer | 8,250 | Option exercise at $34.30 | $283,000 | |
MMay 13 2013 | ONXX | Onyx Pharmaceuticals Inc | Torley Helen | EVP, Chief Commercial Officer | 8,250 | Sale at $98.13 | $809,610 | |
May 13 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 10,269 | Option exercise at $34.48 | $354,075 | |
MMay 13 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 10,269 | Sale at $98.22 | $1,008,598 | |
MMay 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Foster-Cheek Kaye I | SVP, Global HR | 8,877 | Option exercise at $31.15 | $276,548 | |
MMay 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Foster-Cheek Kaye I | SVP, Global HR | 8,877 | Sale at $89.84 | $797,496 | |
May 8 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 1,000 | Option exercise at $28.41 | $28,410 | |
May 8 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 1,000 | Sale at $95.00 | $95,000 | |
MMay 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 4,051 | Option exercise at $34.30 | $138,966 | |
MMay 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 4,051 | Sale at $89.97 | $364,484 | |
MMay 6 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 4,500 | Option exercise at $26.34 | $118,510 | |
May 6 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 4,500 | Sale at $91.01 | $409,545 | |
MMay 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 5,000 | Option exercise at $15.68 | $78,410 | |
MMay 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 5,000 | Sale at $93.02 | $465,087 | |
Apr 23 2013 | ONXX | Onyx Pharmaceuticals Inc | Grillo Lopez Antonio J | Director | 5,000 | Option exercise at $37.68 | $188,400 | |
Apr 23 2013 | ONXX | Onyx Pharmaceuticals Inc | Grillo Lopez Antonio J | Director | 5,000 | Sale at $101.28 | $506,400 | |
Apr 15 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 1,347 | Sale at $95.15 | $128,167 | |
MApr 11 2013 | ONXX | Onyx Pharmaceuticals Inc | Grillo Lopez Antonio J | Director | 43,164 | Option exercise at $29.24 | $1,261,932 | |
MApr 11 2013 | ONXX | Onyx Pharmaceuticals Inc | Grillo Lopez Antonio J | Director | 43,164 | Sale at $96.73 | $4,175,114 | |
MApr 10 2013 | ONXX | Onyx Pharmaceuticals Inc | Wood Julianna R | VP, Public Affairs | 9,948 | Option exercise at $33.98 | $338,072 | |
MApr 10 2013 | ONXX | Onyx Pharmaceuticals Inc | Wood Julianna R | VP, Public Affairs | 9,948 | Sale at $95.00 | $945,071 | |
Apr 11 2013 | ONXX | Onyx Pharmaceuticals Inc | Lundberg Magnus | Director | 10,000 | Option exercise at $16.28 | $162,800 | |
Apr 11 2013 | ONXX | Onyx Pharmaceuticals Inc | Lundberg Magnus | Director | 10,000 | Sale at $96.00 | $960,000 | |
Apr 10 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 2,000 | Option exercise at $28.41 | $56,820 | |
Apr 10 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 2,000 | Sale at $95.00 | $190,000 | |
MApr 8 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 4,052 | Option exercise at $34.31 | $139,007 | |
MApr 8 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 4,052 | Sale at $89.18 | $361,338 | |
Apr 5 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 2,500 | Option exercise at $25.30 | $63,250 | |
MApr 5 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 3,700 | Sale at $86.00 | $318,200 | |
MApr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 5,215 | Sale at $88.14 | $459,659 | |
MApr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Grillo Lopez Antonio J | Director | 25,000 | Option exercise at $24.15 | $603,750 | |
MApr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Grillo Lopez Antonio J | Director | 25,000 | Sale at $91.36 | $2,284,016 | |
MApr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Coles N Anthony | Chairman, CEO | 21,334 | Sale at $87.67 | $1,870,342 | |
MApr 3 2013 | ONXX | Onyx Pharmaceuticals Inc | Coles N Anthony | Chairman, CEO | 17,278 | Option exercise at $28.93 | $499,899 | |
MApr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Lasowski Juergen | EVP, Corp. Dev, Strategy | 2,651 | Sale at $86.14 | $228,350 | |
Apr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Lundberg Magnus | Director | 10,000 | Option exercise at $23.70 | $237,000 | |
Apr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Lundberg Magnus | Director | 10,000 | Sale at $92.00 | $920,000 | |
MApr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Foster-Cheek Kaye I | SVP, Global HR | 3,833 | Sale at $87.75 | $336,344 | |
MApr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 3,861 | Sale at $86.14 | $332,575 | |
Apr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Torley Helen | EVP, Chief Commercial Officer | 466 | Sale at $86.14 | $40,141 | |
Apr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Wood Julianna R | VP, Public Affairs | 438 | Option payment at $88.86 | $38,921 | |
Apr 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Wood Julianna R | VP, Public Affairs | 907 | Sale at $86.15 | $78,138 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Lundberg Magnus | Director | 2,100 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Grillo Lopez Antonio J | Director | 2,100 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Torley Helen | EVP, Chief Commercial Officer | 8,600 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 2,100 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Nevinny Corinne H | Director | 2,100 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Wood Julianna R | VP, Public Affairs | 2,500 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Lasowski Juergen | EVP, Corp. Dev, Strategy | 7,100 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 6,000 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 2,100 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Ringo William R | Director | 2,100 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Foster-Cheek Kaye I | SVP, Global HR | 5,400 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Wierenga Wendall | Director | 2,100 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 8,000 | Grant at $0.00 | $0 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Coles N Anthony | Chairman, CEO | 10,938 | Option exercise at $35.18 | $384,799 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Coles N Anthony | Chairman, CEO | 10,938 | Sale at $90.00 | $984,420 | |
Mar 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Coles N Anthony | Chairman, CEO | 26,800 | Grant at $0.00 | $0 | |
Mar 11 2013 | ONXX | Onyx Pharmaceuticals Inc | Cagnoni Pablo J | EVP, Global R, D, Tech Ops | 16,257 | Grant at $0.00 | $0 | |
MMar 11 2013 | ONXX | Onyx Pharmaceuticals Inc | Wood Julianna R | VP, Public Affairs | 3,331 | Option exercise at $33.32 | $110,990 | |
Mar 11 2013 | ONXX | Onyx Pharmaceuticals Inc | Wood Julianna R | VP, Public Affairs | 3,331 | Sale at $85.65 | $285,300 | |
Mar 11 2013 | ONXX | Onyx Pharmaceuticals Inc | Lundberg Magnus | Director | 5,000 | Option exercise at $38.85 | $194,250 | |
Mar 11 2013 | ONXX | Onyx Pharmaceuticals Inc | Lundberg Magnus | Director | 5,000 | Sale at $88.00 | $440,000 | |
Mar 8 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 2,000 | Option exercise at $27.63 | $55,260 | |
Mar 8 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 2,000 | Sale at $85.00 | $170,000 | |
Mar 8 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 1,000 | Option exercise at $28.41 | $28,410 | |
Mar 8 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 1,000 | Sale at $85.00 | $85,000 | |
MMar 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 4,054 | Option exercise at $34.30 | $139,072 | |
Mar 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 4,054 | Sale at $79.72 | $323,185 | |
Mar 5 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 2,211 | Option exercise at $34.48 | $76,235 | |
Mar 5 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 2,500 | Option exercise at $25.30 | $63,250 | |
Mar 5 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 2,500 | Sale at $77.20 | $193,000 | |
Mar 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 4,000 | Option exercise at $12.50 | $50,000 | |
Mar 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 4,000 | Sale at $74.35 | $297,400 | |
Feb 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 10,000 | Option exercise at $34.48 | $344,800 | |
Feb 28 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 15,000 | Sale at $77.12 | $1,156,800 | |
MFeb 15 2013 | ONXX | Onyx Pharmaceuticals Inc | Foster-Cheek Kaye I | SVP, Global HR | 16,164 | Option exercise at $30.51 | $493,186 | |
Feb 15 2013 | ONXX | Onyx Pharmaceuticals Inc | Foster-Cheek Kaye I | SVP, Global HR | 16,164 | Sale at $74.96 | $1,211,653 | |
MFeb 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 4,051 | Option exercise at $34.31 | $138,972 | |
Feb 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 4,051 | Sale at $77.52 | $314,034 | |
Feb 5 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 2,500 | Option exercise at $25.30 | $63,250 | |
Feb 5 2013 | ONXX | Onyx Pharmaceuticals Inc | Wiggans Thomas G | Director | 2,500 | Sale at $77.29 | $193,225 | |
MFeb 4 2013 | ONXX | Onyx Pharmaceuticals Inc | Torley Helen | EVP, Chief Commercial Officer | 8,250 | Option exercise at $34.30 | $283,000 | |
Feb 4 2013 | ONXX | Onyx Pharmaceuticals Inc | Torley Helen | EVP, Chief Commercial Officer | 8,250 | Sale at $78.61 | $648,533 | |
Feb 1 2013 | ONXX | Onyx Pharmaceuticals Inc | Wierenga Wendall | Director | 250 | Sale at $77.71 | $19,428 | |
Jan 10 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 7,112 | Option exercise at $34.48 | $245,222 | |
MJan 10 2013 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 10,199 | Sale at $84.87 | $865,582 | |
MJan 9 2013 | ONXX | Onyx Pharmaceuticals Inc | Wood Julianna R | VP, Public Affairs | 6,622 | Option exercise at $34.32 | $227,244 | |
Jan 9 2013 | ONXX | Onyx Pharmaceuticals Inc | Wood Julianna R | VP, Public Affairs | 6,622 | Sale at $85.00 | $562,870 | |
Jan 9 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 5,000 | Option exercise at $33.56 | $167,800 | |
MJan 9 2013 | ONXX | Onyx Pharmaceuticals Inc | Goddard Paul | Director | 5,000 | Sale at $83.20 | $416,000 | |
MJan 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 6,240 | Option exercise at $35.37 | $220,724 | |
MJan 7 2013 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 6,240 | Sale at $81.33 | $507,494 | |
Dec 12 2012 | ONXX | Onyx Pharmaceuticals Inc | Grillo Lopez Antonio J | Director | 7,265 | Sale at $82.25 | $597,546 | |
MDec 10 2012 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 12,084 | Option exercise at $35.99 | $434,905 | |
Dec 10 2012 | ONXX | Onyx Pharmaceuticals Inc | Shema Suzanne M | EVP, GC, Corp. Secretary | 14,398 | Sale at $77.68 | $1,118,437 | |
Nov 28 2012 | ONXX | Onyx Pharmaceuticals Inc | Nevinny Corinne H | Director | 3,964 | Sale at $75.00 | $297,300 | |
Nov 28 2012 | ONXX | Onyx Pharmaceuticals Inc | Fust Matthew K | EVP, CFO | 966 | Option exercise at $34.48 | $33,308 |
M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance